Novo Holdings, the controlling shareholder of drug maker Novo Nordisk, said on Wednesday that its total income and investment return in 2024 nearly doubled to DKK 60 billion ($8.69 billion ...

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Felix. In this article, we will summarize the bulls’ thesis on NVO. Novo Nordisk A/S (NVO)'s share was trading at $64.49 ...

The company is the majority shareholder of Novo Nordisk A/S and Novonesis A/S and manages a portfolio of stocks, bonds, real estate, infrastructure and private equity assets in the field of natural ...

Novonesis, formerly Chr. Hansen Inc., wants to build a two-story, 50,200-square-foot addition for new production equipment, according to a West Allis Plan Commission report. The addition would be ...

WASHINGTON, April 11, 2025 /PRNewswire/ -- Novonesis, a world-leading biosolutions company, recognizes the importance of the National Security Commission on Emerging Biotechnology (NSCEB ...

Novo Nordisk, the Danish pharmaceutical giant behind obesity drug, Wegovy, has engaged Slingshot to develop and manage its first consumer campaign in Australia. Novo Nordisk has previously focused ...